- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04531254
Back to School COVID-19 Simulation Study
November 25, 2022 updated by: Michelle Science, The Hospital for Sick Children
Understanding the Impact of Public Health Measures Planned for School Reopening During COVID-19 Using Simulation Exercises
This will be a prospective study simulating return to school for two full days prior to the start of the school year in September.
Volunteer students and teachers from six grade ranges will be recruited to participate in the study.
In each grade range, there will be two classes that will participate, one that will be assigned to wear face masks/coverings at all times (experimental group/class) and the other that will not wear face masks/coverings at all times (control group/class).
Students will be randomized to either the masking at all times (experimental across all grades) or no masking (control across JK-Grade 4) / masking only when physical distance can be maintained (control across Grade 5-Grade 12) class in their appropriate grade.
Personal behaviours and person-to-person interactions will be recorded using video cameras.
In addition, a safe biological indicator will be applied to the hands to simulate potential asymptomatic infection in a subset of students.
Other students will have sanitizer applied so that students are blinded to who has the indicator.
Cameras will be used to document how the indicator moves throughout the classroom.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Grade ranges will include 1) Senior Kindergarten (children who have just completed JK or SK in the 2019-2020 year), 2) Grades 1-2, 3) Grades 3-4, 4) Grades 5-6, 5) Grades 7-8 and 6) high school.
A total of 14 teachers and up to 240 students will be recruited.
Final class sizes will be in accordance with Ministry of Education and public health guidelines.
Study Type
Interventional
Enrollment (Actual)
174
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
• To be included in the study, students must have attended a structure learning environment during 2019-2020 school year and provide informed consent (student in Grade 7 or older) or parental consent (SK - Grade 6) and assent (if appropriate). To be included in the study, teachers must be certified teachers and provide informed consent to participate.
Exclusion Criteria:
- require additional resources or support beyond what can be provided by the single class teacher
- have been exposed to an individual that has tested positive for COVID-19 in the 14 days prior to the simulation
- test positive for COVID-19 in the 14 days prior to the simulation
- have signs or symptoms of COVID-19, as identified on the screening form (See Screening Form) before the simulations
- travel outside Canada in the last 14 days
- known hypersensitivity or allergy to the biological indicator (Fluorescein dye/GloGerm)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Masking at all times
Children in this group will be asked to wear a face mask/covering in the classroom and common areas during the simulation
|
Children in this group will be asked to wear a face mask in the classroom and common areas during the simulation
|
|
NO_INTERVENTION: No mask/masking when physical distancing is not maintained
Children in this group will not be asked to wear a mask (JK-Grade 4) or only asked to wear a mask when physical distancing in the classroom cannot be maintained (Grade 5-Grade 12) during the simulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total number of hand-to-face contacts per participant per hour
Time Frame: Day 2
|
The number of touches to the face made per hour in the simulated school environment
|
Day 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total number of hand-to-mucus membrane contacts per participant per hour
Time Frame: Day 2
|
The number of touches to the eyes, nose, mouth made per hour in the simulated school environment
|
Day 2
|
|
Total number of hand-to-non-mucus membrane contacts per participant per hour
Time Frame: Day 2
|
The number of touches to the skin (not eyes, nose, mouth) made per hour in the simulated school environment
|
Day 2
|
|
Total number of instances where participants are within 1 and 2 meters of each other
Time Frame: Day 2
|
The number of instances where 1 and 2 meter distance between participants is breached in the classroom
|
Day 2
|
|
Total number of glo germ transfers to another person
Time Frame: Day 2
|
The number of children within a classroom with Glo Germ on the hands/face
|
Day 2
|
|
Total number of glo germ transfers to teacher
Time Frame: Day 2
|
The presence of Glo Germ on the hands/face of teacher within the same classroom
|
Day 2
|
|
Total number of glo germ transfers to a surface
Time Frame: Day 2
|
The number of surfaces in the classroom with Glo Germ
|
Day 2
|
|
Total number of instances of hand holding per participant per hour
Time Frame: Day 2
|
The count of hand holding instances with another person per hour in the simulated school environment
|
Day 2
|
|
Total number of touches to another person per participant per hour
Time Frame: Day 2
|
The count of touches to another person per hour in the simulated school environment
|
Day 2
|
|
Total number of hand hygiene actions per participant per hour
Time Frame: Day 2
|
The count of hand hygiene actions (i.e., hand washing, hand sanitizer) per participant per hour
|
Day 2
|
|
Total number of mask removals per participant per hour
Time Frame: Day 2
|
The number of times a participant in a masking group removes their mask per hour in the simulated school environment
|
Day 2
|
|
Teacher concerns measured using study-specific post-simulation questionnaire
Time Frame: Day 2
|
A study specific questionnaire that examines teacher anxiety and mental health
|
Day 2
|
|
Teacher concerns measured using semi-structured group interviews
Time Frame: Day 2
|
A study specific semi-structured interview examining the factors throughout the day (hand hygiene, mask use, physical distancing) that impacted the teaching experience
|
Day 2
|
|
Student concerns measured using study-specific post-simulation questionnaire
Time Frame: Day 2
|
A study specific questionnaire that examines student anxiety and mental health
|
Day 2
|
|
Student concerns measured using semi-structured group interviews
Time Frame: Day 2
|
A study specific semi-structured interview examining the factors throughout the day (hand hygiene, mask use, physical distancing) that impacted the learning experience
|
Day 2
|
|
Identify activity types that influence touching behaviour
Time Frame: Day 2
|
The count of each type of activity participants are engaged in while touching others or surfaces in the simulated school environment
|
Day 2
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michelle Science, The Hospital for Sick Children
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 10, 2020
Primary Completion (ACTUAL)
August 31, 2020
Study Completion (ACTUAL)
August 31, 2020
Study Registration Dates
First Submitted
August 24, 2020
First Submitted That Met QC Criteria
August 27, 2020
First Posted (ACTUAL)
August 28, 2020
Study Record Updates
Last Update Posted (ACTUAL)
November 30, 2022
Last Update Submitted That Met QC Criteria
November 25, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000071861
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on Wearing a face mask at all times
-
University of SaskatchewanSaskatchewan Health Research FoundationCompleted
-
University of GöttingenCompleted
-
Patrick BrooksMissouri State UniversityCompletedCarbon DioxideUnited States
-
Santa Clara Valley Health & Hospital SystemCompletedSurgical Site InfectionUnited States
-
University of AlbertaCompletedRespiration; Insufficient or Poor, NewbornCanada
-
Medical University of ViennaRecruiting
-
King Faisal Specialist Hospital & Research CenterRecruiting
-
Massachusetts General HospitalWithdrawnChronic Obstructive Pulmonary DiseaseUnited States
-
University of New MexicoCompletedHypoxemia | Physiological StressUnited States
-
Irish Research Radiation Oncology GroupRecruiting